Pages that link to "Item:Q1621032"
From MaRDI portal
The following pages link to Estimating and comparing cancer progression risks under varying surveillance protocols (Q1621032):
Displaying 6 items.
- A stochastic approach to risk management for prostate cancer patients on active surveillance (Q1786034) (← links)
- Bayesian inference for continuous-time hidden Markov models with an unknown number of states (Q2058798) (← links)
- Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II (Q5868268) (← links)
- Tailored optimal posttreatment surveillance for cancer recurrence (Q6076506) (← links)
- A Bayesian accelerated failure time model for interval censored three-state screening outcomes (Q6104113) (← links)
- The heterogeneity effect of surveillance intervals on progression free survival (Q6547171) (← links)